• Hemant U. Chikhale
• Sandeep R Purkar
• Dr. Sunil V. Amrutkar

The repositioning of drugs generates new use of a drug that already exists. It offers safe, reliable and faster treatment Drug position provides an additional advantage over new drug manufacturing as a result of reducing drug production costs as they have already been protected by safety and alternative measures, along with clinical trials. The flourishing position of medicines that holds an amazing future within the trendy medical sector can be stimulated by consciousness and inspiration. Exceptional improvements have been made in global standards, which will improve health care and nutrition. As there is clinical and pharmacokinetic evidence for current treatment, drug placement is a faster path of drug development. New approaches to the case of medicinal drugs, such as the reprocessing of patented medicinal products, would not be taken into account in the treatment of various diseases. This article focuses on drug pharmacology, pharmacodynamic, and safety profiles that are already known, undoubtedly allowing diagnostic studies to predominate

Drug Repositioning, Pharmacokinetics, Pharmacodynamic, Preclinical Studies

"DRUG REPOSITIONING: AN OVERVIEW AND CLINICAL PERSPECTIVE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.7, Issue 11, page no.816-821, November-2020, Available :http://www.jetir.org/papers/JETIR2011390.pdf

"DRUG REPOSITIONING: AN OVERVIEW AND CLINICAL PERSPECTIVE", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.7, Issue 11, page no. pp816-821, November-2020, Available at : http://www.jetir.org/papers/JETIR2011390.pdf